Q'Apel Medical designs access device technology for neurovascular interventions and unmet clinical needs.
Q'Apel Medical has raised $17.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Q'Apel Medical's investors include Soleus Capital, RC Capital, Research Corporation Technologies.
Q'Apel Medical is headquartered in Fremont, United States.
Q'Apel Medical designs access device technology for neurovascular interventions and unmet clinical needs.
Q'Apel Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Q'Apel Medical — Funding & Investors." VCBacked, May 9, 2024, https://www.vcbacked.co/company/qapel-medical. Accessed September 30, 2026.
VCBacked. (2024). Q'Apel Medical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/qapel-medical
{{cite web |title=Q'Apel Medical — Funding & Investors |url=https://www.vcbacked.co/company/qapel-medical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated